Beverly Assman

1.4k total citations · 1 hit paper
4 papers, 837 citations indexed

About

Beverly Assman is a scholar working on Infectious Diseases, Molecular Biology and Surgery. According to data from OpenAlex, Beverly Assman has authored 4 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Infectious Diseases, 2 papers in Molecular Biology and 1 paper in Surgery. Recurrent topics in Beverly Assman's work include Ethics in Clinical Research (1 paper), Biochemical and Molecular Research (1 paper) and Neurogenetic and Muscular Disorders Research (1 paper). Beverly Assman is often cited by papers focused on Ethics in Clinical Research (1 paper), Biochemical and Molecular Research (1 paper) and Neurogenetic and Muscular Disorders Research (1 paper). Beverly Assman collaborates with scholars based in United States, Switzerland and Spain. Beverly Assman's co-authors include Emma Kaplan‐Lewis, Benjamin Krämer, William Reiss, Carlos Salama, Reena Shah, Shalini Mohan, Jamie Freedman, Jeffrey D. Neidhart, Julia Garcia‐Diaz and Miriam L. Cameron and has published in prestigious journals such as New England Journal of Medicine, EClinicalMedicine and Annals of Clinical and Translational Neurology.

In The Last Decade

Beverly Assman

4 papers receiving 820 citations

Hit Papers

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia 2020 2026 2022 2024 2020 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beverly Assman United States 4 620 424 114 92 81 4 837
Jamie Freedman United States 6 621 1.0× 424 1.0× 107 0.9× 113 1.2× 100 1.2× 11 870
Carlos Salama United States 7 656 1.1× 426 1.0× 93 0.8× 94 1.0× 81 1.0× 12 862
Jia Feng China 7 656 1.1× 325 0.8× 102 0.9× 161 1.8× 68 0.8× 13 859
Işık Atagündüz Türkiye 6 464 0.7× 240 0.6× 154 1.4× 62 0.7× 42 0.5× 23 753
Sebastian Havervall Sweden 13 533 0.9× 412 1.0× 210 1.8× 66 0.7× 70 0.9× 26 948
Phil‐Robin Tepasse Germany 12 419 0.7× 236 0.6× 87 0.8× 61 0.7× 67 0.8× 41 683
Zhiping Zhang China 9 412 0.7× 196 0.5× 83 0.7× 149 1.6× 103 1.3× 27 757
Katherine Xu United States 11 415 0.7× 154 0.4× 101 0.9× 117 1.3× 49 0.6× 20 872
Catherine Kimber United Kingdom 12 573 0.9× 194 0.5× 33 0.3× 69 0.8× 42 0.5× 17 818

Countries citing papers authored by Beverly Assman

Since Specialization
Citations

This map shows the geographic impact of Beverly Assman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly Assman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly Assman more than expected).

Fields of papers citing papers by Beverly Assman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverly Assman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly Assman. The network helps show where Beverly Assman may publish in the future.

Co-authorship network of co-authors of Beverly Assman

This figure shows the co-authorship network connecting the top 25 collaborators of Beverly Assman. A scholar is included among the top collaborators of Beverly Assman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beverly Assman. Beverly Assman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Brangman, Sharon A., Jacobo Mintzer, Michael Grundman, et al.. (2024). Promoting diversity in clinical trials: insights from planning the ALUMNI AD study in historically underrepresented US populations with early symptomatic Alzheimer's disease. EClinicalMedicine. 73. 102693–102693. 5 indexed citations
2.
Kwon, Jennifer M., Kapil Arya, Nancy L. Kuntz, et al.. (2022). An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy. Annals of Clinical and Translational Neurology. 9(6). 810–818. 26 indexed citations
3.
Salama, Carlos, Jian Han, Linda Yau, et al.. (2020). Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia. New England Journal of Medicine. 384(1). 20–30. 798 indexed citations breakdown →
4.
Kuilenburg, André B. P., Rutger Meinsma, Beverly Assman, et al.. (2006). Genetic Analysis of the First 4 Patients with β-Ureidopropionase Deficiency. Nucleosides Nucleotides & Nucleic Acids. 25(9-11). 1093–1098. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026